Altered awareness of motor symptoms in Parkinson's disease and Dementia with Lewy Bodies: A systematic review
Open Access
- 11 June 2020
- journal article
- review article
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 35 (9) , 972-981
Abstract
Objectives: Altered awareness of motor symptoms is reported in people with Parkinson's disease and Dementia with Lewy Bodies, and may adversely affect quality of life and medication concordance. How symptom awareness is influenced by motor and cognitive disease severity, age and medication use is not fully understood. We carried out a systematic review of the literature on motor symptom awareness in Parkinson's disease and Dementia with Lewy Bodies.Methods: Pubmed and Wed of Science were searched for relevant articles published in or prior to March 2019. Data regarding participant demographics, diagnosis, cognitive status, method of assessing awareness and study findings were extracted from relevant publications.Results: Sixteen relevant publications were identified. Motor symptom awareness appears to decline over the course of Parkinson's disease. Imaging studies implicate the prefrontal cortex, with different mechanisms involved in hypokinesia and dyskinesia awareness. The hypothesis that people with right hemisphere based disease would have more severely reduced awareness is only weakly supported. Most studies focused on cognitively intact individuals, and on awareness of dyskinesia rather than hypokinesia.Conclusions: Whilst reduced awareness of dyskinesia and to a lesser extent hypokinesia is common, there is a lack of longitudinal data on how awareness changes over time, and how it interacts with global cognitive changes. Motor symptom awareness in Dementia with Lewy Bodies is understudied. Future studies of symptom awareness should include robust assessment of overall cognitive functioning, and use a longitudinal design to elucidate how awareness changes over time. J Am Geriatr Soc 68:‐, 2020.Keywords
Funding Information
- Chief Scientist Office
- Innovative Medicines Initiative (115736 (EPAD))
- Merck
- Janssen Pharmaceutica
- Biogen
This publication has 50 references indexed in Scilit:
- Dopamine is a double-edged sword: dopaminergic modulation enhances memory retrieval performance but impairs metacognitionNeuropsychopharmacology, 2018
- Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: Frequency and neuropsychological/neuropsychiatric correlatesParkinsonism & Related Disorders, 2018
- A Systematic Review of Metacognitive Differences Between Alzheimer’s Disease and Frontotemporal DementiaAmerican Journal of Alzheimer's Disease and Other Dementias®, 2016
- MDS clinical diagnostic criteria for Parkinson's diseaseMovement Disorders, 2015
- Making sense: Dopamine activates conscious self‐monitoring through medial prefrontal cortexHuman Brain Mapping, 2015
- Insight and danger in Alzheimer's diseaseEuropean Journal of Neurology, 2007
- Unawareness of Deficits in Alzheimer's Disease and Other Dementias: Operational Definitions and Empirical FindingsNeuropsychology Review, 2005
- Metamemory Experiments in Neurological Populations: A ReviewNeuropsychology Review, 2005
- Self-Awareness of Deficits in Parkinson DiseaseThe Clinical Neuropsychologist, 2004
- Toward a Cognitive Neuroscience of MetacognitionConsciousness and Cognition, 2000